Direct identification of major histocompatibility complex class I-bound tumor-associated peptide antigens of a renal carcinoma cell line by a novel mass spectrometric method

Cancer Research

Volumn 58, Issue 24, 1998, Pages 5803-5811

  Flad, Thomas ^a   Spengler, Bernhard ^b   Kaibacher, Hubert ^a   Brossart, Peter ^a   Baier, Daniel ^a   Kaufmann, Raimund ^b   Bold, Peter ^b   Metzger, Sabine ^b   Blüggel, Martin ^c   Meyer, Helmut E ^c   Kurz, Bernd ^a   Müller, Claudia A ^a,d  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A2 ANTIGEN; HLA B8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; SYNTHETIC PEPTIDE; TUMOR ANTIGEN;

AMINO ACID SEQUENCE; ARTICLE; CYTOTOXIC T LYMPHOCYTE; GENE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; KIDNEY CARCINOMA; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL;

EID: 17444369342     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Gross, L. Intradermal immunization of C3H mice against a sarcoma that originated in an animal of the same line. Cancer Res., 3: 326, 1943.
2. Pardoll, D. M. Cancer vaccines: a road map for the next decade. Curr. Opin. Immunol., 8: 619-621, 1996.
3. Roth, C., Rochlitz, C., and Kourilsky, P. Immune response against tumors. Adv. Immunol., 57: 281-350, 1994.
4. van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., and Boon, T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Washington DC), 254: 1643-1647, 1991.
5. Traversari, C., van der Bruggen, P., Luescher, I. F., Lurquin, C, Chomez, P., Van Pel, A., De Plaen, E., Amar-Costesec, A., and Boon, T. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med., 176: 1453-1457, 1992.
6. Van den Eynde, B., Peeters, O., De Backer, O., Gaugler, B., Lucas, S., and Boon, T. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med., 182: 689-698, 1995.
7. Traversari, C., van der Bruggen, P., Van den Eynde, B., Hainaut, P., Lemoine, C., Ohta, N., Old, L., and Boon, T. Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics, 35: 145-152, 1992.
8. Maeurer, M. J., Storkus, W. J., Kirkwood, J. M., and Lotze, M. T. New treatment options for patients with melanoma: review of melanoma-derived T-cell epitope-based peptide vaccines. Melanoma Res., 6: 11-24, 1996.
9. Salvadori, S., and Zier, K. Molecular basis of T cell dysfunction in cancer is influenced by the paracrine secretion of tumor-derived IL-2. J. Immunol., 156: 2927-2932, 1996.
10. Kolenko, V., Wang, Q., Riedy, M. C., O'Shea, J., Ritz, J., Cathcart, M. K., Rayman, P., Tubbs, R., Edinger, M, Novick, A., Bukowski, R., and Finke, J. Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas. J. Immunol., 159: 3057-3067, 1997.
11. Enk, A. H., Jonuleit, H., Saloga, J., and Knop, J. Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Int. J. Cancer, 73: 309-316, 1997.
12. Engelhard, V. H. Direct identification of tumor associated peptide antigens. Springer Semin. Immunopathol., 18: 171-183, 1996.
13. Roetzschke, O., Falk, K., Wallny, H. J., Faath, S., and Rammensee, H. G. Characterization of naturally occurring minor histocompatibility peptides including H-4 and H-Y. Science (Washington DC), 249: 283-287, 1990.
14. Van Bleek, G., and Nathanson, S. Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kb molecule. Nature (Lond.), 348: 213-216, 1990.
15. Mandelboim, O., Berke, G., Fridkin, M., Feldman, M., Eisenstein, M., and Eisenbach, L. CTL induction by a tumor-associated antigen octapeptide derived from a murine lung carcinoma. Nature (Lond.), 369: 67-71, 1994.
16. Papadopoulos, K. P., Suicu-Foca, N., Hesdorffer, C. S., Tugulea, S., Maffei, A., and Harris, P. E. Naturally processed tissue- and differentiation stage-specific autologous peptides bound by HLA class I and II molecules of chronic myeloid leukemia blasts. Blood, 90: 4938-4946, 1997.
17. Henderson, R. A., Cox, A. L., Sakaguchi, K., Appella, E., Shabanowitz, J., Hunt, D. F., and Engelhard, V. H. Direct identification of an endogenous peptide recognized by multiple HLA-A2.1 specific cytotoxic T cells. Proc. Natl. Acad. Sci. USA, 90: 10275-10279, 1993.
18. Cox, A. L., Skipper, J., Chen, Y., Henderson, R. A., Darrow, T. L., Shabanowitz, J., Engelhard, V. H., Hunt, D. F., and Slingluff, C. L., Jr. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science (Washington DC), 264: 716-719, 1994.
19. Gaugler, B., Brouwenstijn, N., Vantomme, V., Szikora, J. P., Van der Spek, C. W., Patard, J. J., Boon, T., Schrier, P., and Van den Eynde, B. J. A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinoma. Immunogenetics, 44: 323-330, 1996.
20. Barnstable, C. J., Bodmer, W. F., Brown, G., Galfré, G., Milstein, C., Williams, A. F., and Ziegler, A. Production of monoclonal antibodies to group A erythrocytes, HLA, and other human cell surface antigens -new tools for genetic analysis. Cell, 14: 9-20, 1978.